- Patent Title: Uses of benzimidazole derivative for nocturnal acid breakthrough
-
Application No.: US16676659Application Date: 2019-11-07
-
Publication No.: US11033532B2Publication Date: 2021-06-15
- Inventor: Ha Jin Lee , Bong Tae Kim , Hyun Kim , Ji Yeon Nam , Jie Eun Park , Geun Seog Song , Shin Young Ryu , Shinichi Koizumi , Nobuyuki Takahashi , Masaomi Tajimi
- Applicant: HK INNO.N CORPORATION
- Applicant Address: KR Seoul
- Assignee: HK INNO.N CORPORATION
- Current Assignee: HK INNO.N CORPORATION
- Current Assignee Address: KR Seoul
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; A61K9/28 ; A61K9/20 ; A61P1/04
Abstract:
The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can more effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.
Public/Granted literature
- US20200069652A1 USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH Public/Granted day:2020-03-05
Information query
IPC分类:
